康莱特注射液是我国研制的双相广谱抗癌新药．1996年产量60万瓶，700多家大中型医院临床应用．产品少量出口至美国、日本、韩国、新加坡、泰国、科威特、香港等国家和地区。临床证实该药对肺癌、肝癌、胃痛、乳腺癌等实体瘤以及其它伴有转移的中晚期恶性肿痛分较好的疗效，销售 Kanglaite Injection is a dual-phase broad-spectrum anti-cancer drug developed in China. Production of 600,000 bottles in 1996, more than 700 large and medium-sized hospital clinical applications. A small amount of products exported to the United States, Japan, Korea, Singapore, Thailand, Kuwait, Hong Kong and other countries and regions. Clinically confirmed that the drug on lung cancer, liver cancer, stomach pain, breast cancer and other solid tumors, as well as with the transfer of advanced malignant pain score points better effect, sales